Psoriasis
>
Latest News
Tildrakizumab Shows Efficacy for Nail Psoriasis in Phase 3b Trial
March 7th 2025
The findings highlight the potential of the interleukin-23 inhibitor to address a notoriously difficult-to-treat manifestation of psoriasis.
March 7th 2025
The findings highlight the potential of the interleukin-23 inhibitor to address a notoriously difficult-to-treat manifestation of psoriasis.
